Geode Capital Management LLC Has $86.43 Million Stock Position in National Health Investors, Inc. $NHI

Geode Capital Management LLC boosted its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 4.5% during the second quarter, Holdings Channel reports. The fund owned 1,232,524 shares of the real estate investment trust’s stock after acquiring an additional 53,630 shares during the period. Geode Capital Management LLC’s holdings in National Health Investors were worth $86,434,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NHI. Bank of New York Mellon Corp raised its stake in shares of National Health Investors by 3.2% in the second quarter. Bank of New York Mellon Corp now owns 607,913 shares of the real estate investment trust’s stock worth $42,627,000 after acquiring an additional 19,042 shares during the last quarter. Centersquare Investment Management LLC increased its holdings in shares of National Health Investors by 25.7% in the first quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust’s stock valued at $36,632,000 after purchasing an additional 101,538 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after purchasing an additional 21,851 shares in the last quarter. Sound Income Strategies LLC raised its position in National Health Investors by 8.3% in the 2nd quarter. Sound Income Strategies LLC now owns 230,690 shares of the real estate investment trust’s stock worth $16,176,000 after purchasing an additional 17,608 shares during the last quarter. Finally, MetLife Investment Management LLC lifted its holdings in National Health Investors by 706.6% during the 1st quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust’s stock worth $15,786,000 after buying an additional 187,233 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Performance

Shares of NYSE:NHI opened at $78.91 on Friday. The firm’s 50 day simple moving average is $76.66 and its 200 day simple moving average is $74.51. National Health Investors, Inc. has a fifty-two week low of $65.13 and a fifty-two week high of $80.56. The company has a market capitalization of $3.76 billion, a price-to-earnings ratio of 25.21, a P/E/G ratio of 3.31 and a beta of 0.74. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91.

National Health Investors (NYSE:NHI) last issued its earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, beating the consensus estimate of $1.24 by $0.08. The firm had revenue of $83.36 million during the quarter, compared to the consensus estimate of $85.66 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The business’s quarterly revenue was down 1.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.03 earnings per share. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. As a group, sell-side analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 116.09%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Cantor Fitzgerald initiated coverage on National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 target price for the company. Wells Fargo & Company upped their price target on National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 27th. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Truist Financial boosted their price objective on National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a report on Friday, August 15th. Finally, National Bankshares set a $90.00 target price on shares of National Health Investors in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $84.83.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.